Lv4
760 积分 2021-04-29 加入
Upadacitinib vs adalimumab in patients with rheumatoid arthritis and a prior inadequate response or intolerance to a tumour necrosis factor inhibitor: 12-week results from the randomised, double-blind, SELECT-SWITCH study
1天前
待确认
Alopecia Areata–Specific Patient-Reported Outcome Measures
3天前
已完结
Efficacy of JAK Inhibitors versus DMARDs in the Treatment of Polymyalgia Rheumatica in China
4天前
已完结
Targeted small molecules in Polymyalgia Rheumatica: the emerging role of jak inhibitors beyond glucocorticoids and DMARDs
4天前
已完结
Polymyalgia rheumatica
11天前
已完结
What Is Polymyalgia Rheumatica?
11天前
已完结
Baricitinib in early polymyalgia rheumatica (BACHELOR): a randomised, double-blind, placebo-controlled, parallel-group trial
11天前
已关闭
Advances in the treatment of polymyalgia rheumatica
11天前
已完结
Polymyalgia Rheumatica
11天前
已完结
皖公网安备34019202002308
